EnerFlex +AFA - Lights At The End of The Tunnel. EnerFlex +AFA box

EnerFlex +AFA Cancer Patients
EnerFlex +AFA与癌患者
EnerFlex +AFA Dan Kanser

  • Lung Cancer
  • Various Types Cancer

2 CASE STUDIES by a Consultant Physician in General Hospital Kuala Lumpur, Malaysia

CASE STUDY 1
Patient: Male. Age: 71; Race: Malay
Type of Cancer: Ca Lung Stage 3b
Chemotherapy: Carboplcatin, Gemsar – 2nd Cycle
Centre: General Hospital Kuala Lumpur, Malaysia

Post EnerFlex + AFA 40g daily - after 28 days
Study Symptom Co-existing Symptom(s) before EnerFlex + AFA Improved No Change
Nausea + +  
Constipation +   +
Dizziness      
Diarrhoea      
Flatulence      
Insomnia +   +
Appetite Poor   +
Taste Buds Poor   +

Comment from Physician in-charge:
Patient was feeling better since no more nausea or vomiting. Chemotherapy was taken before EnerFlex + AFA . Thus, improvement in reduction of nausea was obviously due to EnerFlex + AFA. Other conditions remained.

Post EnerFlex + AFA 40g daily - after 56 days
Study Symptom Co-existing Symptom(s) before EnerFlex + AFA Improved No Change
Nausea + +  
Constipation + +  
Dizziness      
Diarrhoea      
Flatulence      
Insomnia + +  
Appetite Poor +  
Taste Buds Poor +  

Comment from Physician in-charge:
Patient was feeling better and better tolerant to sign and symptoms of chemotherapy. Looking better, ambulating and back to work!

CASE STUDY 2
Patient: Male. Age: 59; Race: Malay
Type of Cancer: Well-differentiated Ca Lung Stage 3b
Operated on 10/10/03
Centre: General Hospital Kuala Lumpur, Malaysia

Post EnerFlex + AFA 40g daily - after 56 days
Study Symptom Co-existing Symptom(s) before EnerFlex + AFA Improved No Change
Nausea +    
Constipation + +  
Dizziness +    
Diarrhoea -    
Flatulence -    
Insomnia +    
Appetite Poor +  
Taste Buds Poor    

Comment from Physician in-charge:
Patient showed improvement in symptoms.

A 4-week follow-up observational study by Nilai Cancer Hospital, Malaysia

Stomach Cancer, NPC, Breast Cancer, Lung Cancer, Osteoblast Cancer, Sigmoid Colon Cancer, Malignant Mixed Mullerian Tumour, Giant Cell Tumour

LUNG CANCER
Patient: Female. Age: 38; Race: Chinese
Type of Cancer: Ca Lung
Chemotherapy: i.v. Taxotere 20mgm/weekly x 6 weeks
Centre: Nilai Cancer Hospital, Malaysia

Post EnerFlex + AFA 40g daily - after 28 days
Study Symptom Co-existing Symptom(s) before EnerFlex + AFA Improved No Change
Nausea   +  
Constipation      
Dizziness +   +
Diarrhoea      
Flatulence + +  
Insomnia      
Appetite Poor   +
Taste Buds      

Comment from Physician in-charge:
Felt better but no improvement in disease progression yet.

OSTEOSARCOMA
Patient: Female. Age: 16; Race: Chinese
Type of Cancer: Osteosarcoma, Left Knee Joint
Chemotherapy: Not indicated
Centre: Nilai Cancer Hospital, Malaysia

Post EnerFlex + AFA 40g daily - after 28 days
Study Symptom Co-existing Symptom(s) before EnerFlex + AFA Improved No Change
Nausea      
Constipation + +  
Dizziness      
Diarrhoea +/- +  
Flatulence + +  
Insomnia +/- +  
Appetite Good +  
Taste Buds Good +  

Comment from Physician in-charge:
Felt better on regular usage. Very much improved in appetite, taste buds, insomnia and diarrhoea.

CA SIGMOID COLON
Patient: Male. Age: 67; Race: Indian
Type of Cancer: Sigmoid Colon
Chemotherapy: i.v. Folinic acid 35mgm, i.v. 5FU 700mgm; Radiotherapy
Centre: Nilai Cancer Hospital, Malaysia

Post EnerFlex + AFA 40g daily - after 28 days
Study Symptom Co-existing Symptom(s) before EnerFlex + AFA Improved No Change
Nausea      
Constipation      
Dizziness      
Diarrhoea      
Flatulence      
Insomnia +/- +  
Appetite Good +  
Taste Buds Good +  

Comment from Physician in-charge:
Patient complained about abdominal pain after 7 days and stopped consuming. Abdominal pain and fever was due to infection and not the product.

STOMACH CANCER
Patient: Female. Age: 75; Race: Chinese
Type of Cancer: Stomach Cancer
Chemotherapy: UFT 300mg TID, FA 15mg TID
Centre: Nilai Cancer Hospital, Malaysia

Post EnerFlex + AFA 40g daily - after 28 days
Study Symptom Co-existing Symptom(s) before EnerFlex + AFA Improved No Change
Nausea   +  
Constipation      
Dizziness   +  
Diarrhoea      
Flatulence   +  
Insomnia +/- +  
Appetite Average +  
Taste Buds Good +  

Comment from Physician in-charge:
Tolerating well and finds it is useful as all symptoms have subsided considerably.

BREAST CANCER
Patient: Female. Age: 51; Race: Indian
Type of Cancer: Breast Cancer
Chemotherapy: i.v.Taxol 160mgm, i.v.Carboplatin 150mgm
Centre: Nilai Cancer Hospital, Malaysia

Post EnerFlex + AFA 40g daily - after 28 days
Study Symptom Co-existing Symptom(s) before EnerFlex + AFA Improved No Change
Nausea      
Constipation      
Dizziness      
Diarrhoea      
Flatulence   +  
Insomnia +    
Appetite Average +  
Taste Buds Good +  

Comment from Physician in-charge:
Tolerating well and felt better in overall well being.

NPC
Patient: Male. Age: 63; Race: Chinese
Type of Cancer: Nasopharynx Cancer
Chemotherapy: not indicated
Centre: Nilai Cancer Hospital, Malaysia

Post EnerFlex + AFA 40g daily - after 28 days
Study Symptom Co-existing Symptom(s) before EnerFlex + AFA Improved No Change
Nausea      
Constipation + +  
Dizziness      
Diarrhoea      
Flatulence + +  
Insomnia + +  
Appetite Good +  
Taste Buds Good   +

Comment from Physician in-charge:
Comfortable with the product. Much better in bowel movement and appetite, flatulence and insomnia.

GIANT CELL TUMOUR
Patient: Male. Age: 63; Race: Chinese
Type of Cancer: Nasopharynx Cancer
Chemotherapy: not indicated
Centre: Nilai Cancer Hospital, Malaysia

Post EnerFlex + AFA 40g daily - after 28 days
Study Symptom Co-existing Symptom(s) before EnerFlex + AFA Improved No Change
Nausea      
Constipation + +  
Dizziness + +++  
Diarrhoea + +  
Flatulence + +  
Insomnia      
Appetite Average   +
Taste Buds Poor   +

Comment from Physician in-charge:
Happy with the product.

NPC
Patient: Female. Age: 56; Race: Chinese
Type of Cancer: Nasopharynx Cancer
Chemotherapy: not indicated; Radiotherapy
Centre: Nilai Cancer Hospital, Malaysia

Post EnerFlex + AFA 40g daily - after 28 days
Study Symptom Co-existing Symptom(s) before EnerFlex + AFA Improved No Change
Nausea + +  
Constipation      
Dizziness      
Diarrhoea      
Flatulence      
Insomnia + +  
Appetite Average +  
Taste Buds Poor +  

Comment from Physician in-charge:
Well tolerated and found useful as all her symptoms noted improved considerably.

NPC
Patient: Male. Age: 46; Race: Chinese
Type of Cancer: Nasopharynx Cancer
Chemotherapy: not indicated; Radiotherapy
Centre: Nilai Cancer Hospital, Malaysia

Post EnerFlex + AFA 40g daily - after 28 days
Study Symptom Co-existing Symptom(s) before EnerFlex + AFA Improved No Change
Nausea +   +
Constipation      
Dizziness + +  
Diarrhoea + +  
Flatulence +   +
Insomnia +   +
Appetite Poor   +
Taste Buds Poor   +

Comment from Physician in-charge:
Patient felt dryness on the mouth, advised to drink plenty of water.

NPC
Patient: Male. Age: 58; Race: Chinese
Type of Cancer: Nasopharynx Cancer
Chemotherapy: Cisplatin 30mgm/week; Radiotherapy
Centre: Nilai Cancer Hospital, Malaysia

Post EnerFlex + AFA 40g daily - after 28 days
Study Symptom Co-existing Symptom(s) before EnerFlex + AFA Improved No Change
Nausea + +  
Constipation      
Dizziness + +  
Diarrhoea      
Flatulence +   +
Insomnia + +  
Appetite Poor   +
Taste Buds No taste bud   +

Comment from Physician in-charge:
Patient felt better and decided to stay with the product.

STOMACH CANCER
Patient: Male. Age: 49; Race: Indian
Type of Cancer: Stomach Cancer
Chemotherapy: not indicated; Radiotherapy
Centre: Nilai Cancer Hospital, Malaysia

Post EnerFlex + AFA 40g daily - after 28 days
Study Symptom Co-existing Symptom(s) before EnerFlex + AFA Improved No Change
Nausea      
Constipation      
Dizziness      
Diarrhoea      
Flatulence + +  
Insomnia + +  
Appetite Good +  
Taste Buds Good +  

Comment from Physician in-charge:
Patient felt better and decided to stay with the product.